Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

DIURETICS - Pharmacology Lecture, Study notes of Pharmacology

Introduction II. Renal Transport System III. Renal Autacoids IV. Basic Pharmacology of Diuretic Agents V. Agents that Alter Water Excretion (Aquaretics) VI. Clinical Pharmacology of Diuretic Agents

Typology: Study notes

2020/2021

Available from 08/17/2023

Nashville2004
Nashville2004 🇨🇦

5 documents

1 / 7

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Irelia: The Blade Dancer; Jicama
!
1!
DIURETICS
Pharmacology (Lecture)
Dr. Ma. Luisa Crisostomo | March 12, 2021 | Topic 2
INTRODUCTION
Ø Natriuretic agents: increase renal sodium excretion
Ø Aquaretic agents: increase excretion of solute free
water
Ø Diuretic agents: block specific transport functions of
the renal tubules à increase urine volume
RENAL TRANSPORT SYSTEM
NEPHRON
Ø Structural and functional unit of the kidney
Ø Made up of tuft of capillaries called glomerulus
connected to tubes (PCT, DCT, loop of Henle,
collecting tubules)
Ø Responsible for urine formation
1) Glomerular filtration: water and solutes smaller
than proteins are forced through the capillary
walls and force of the glomerular capsule into the
renal tubule
2) Tubular reabsorption: water, glucose, amino
acids and ions are transported out of the filtrate
into the tubular cells and enter the capillary blood
3) Tubular secretion: substances not needed (i.e
drugs, creatinine) the body are removed in the
peritubular blood and secreted into the filter
PROXIMAL CONVOLUTED TUBULE
Ø Reabsorbs
1) Sodium (66%): via the sodium-potassium
ATPase
2) Sodium bicarbonate (NaHCO3;85%): via the
carbonic anhydrase activity
3) Potassium (65%): paracellular pathway
4) Glucose, amino acid (100%) and water (60%):
reabsorbed passively, maintaining osmolality in
nearly constant level
Ø Water permeability of the PCT is very high to
maintain the osmolality of proximal fluid at nearly
constant level, and the gradient from the tubule
lumen to the surrounding interstitium is very small.
DIURETICS THAT ACTS ON INHIBITORS
Ø NaHCO3 reabsorption is initiated by: NaHCO3
Na/H exchanger (NHE3)
Ø Carbonic anhydrase inhibitors: block NaHCO3
reabsorption
Ø Adenosine receptor antagonist: blocks NaCl
reabsorption
LOOP OF HENLE
Ø Pumps Na, K and Cl out of the lumen into the
interstitium
Ø Provides the concentration gradient for the
countercurrent concentrating mechanism
Ø Diluting segment: thick ascending limb of the loop of
Henle
Ø Ca and Mg reabsorption
Ø Na/K/2Cl cotransporter (NKCC2)
Overview
I. Introduction
II. Renal Transport System
III. Renal Autacoids
IV. Basic Pharmacology of Diuretic Agents
V. Agents that Alter Water Excretion
(Aquaretic s)
VI. Clinical Pharmacology of Diuretic Agents
Sodium bicarbonate reabsorption by the PCT is initiated by
the action of a Na+/ H+ exchanger (NHE3) located in the
luminal membrane of the proximal tubule epithelial cell.
This transport system allows Na+ to enter the c ell from the
tubular lume n in exc hange for a proton (H+) from ins ide the
cell. As in all portions of the nephron, Na+/K+-ATPase in the
basolateral membrane pumps the reabsorbed Na+ into the
interstitium in order to maintain a low intracellular Na+
concentration. The H+ secreted into the lumen combines
with bicarbonate (HCO3-) to form H2CO3 (carbonic ac id),
which is rapidly dehydrated to CO2 and H2O by carbonic
anhydrase. Carbon dioxide produced by dehydration of
H2CO3 enters the proximal tubule cell by simple diffusion,
where it is then rehydrated back to H2CO3, facilitated by
intracellula r carbonic an hydrase. A fter dissoc iation of
H2CO3, the H+ is ava ilable for transport by the Na+/H+
exchanger, and the HCO3- is transpo rted out of the cell by
a basolateral membrane transporter
pf3
pf4
pf5

Partial preview of the text

Download DIURETICS - Pharmacology Lecture and more Study notes Pharmacology in PDF only on Docsity!

DIURETICS

Dr. Ma. Luisa Crisostomo | March 12, 2021 | Topic 2

INTRODUCTION

Ø Natriuretic agents : increase renal sodium excretion Ø Aquaretic agents : increase excretion of solute free water Ø Diuretic agents : block specific transport functions of the renal tubules à increase urine volume RENAL TRANSPORT SYSTEM NEPHRON Ø Structural and functional unit of the kidney Ø Made up of tuft of capillaries called glomerulus connected to tubes (PCT, DCT, loop of Henle, collecting tubules) Ø **Responsible for urine formation

  1. Glomerular filtration** : water and solutes smaller than proteins are forced through the capillary walls and force of the glomerular capsule into the renal tubule 2) Tubular reabsorption : water, glucose, amino acids and ions are transported out of the filtrate into the tubular cells and enter the capillary blood 3) Tubular secretion : substances not needed (i.e drugs, creatinine) the body are removed in the peritubular blood and secreted into the filter PROXIMAL CONVOLUTED TUBULE Ø **Reabsorbs
  2. Sodium (66%)** : via the sodium-potassium ATPase 2) Sodium bicarbonate (NaHCO 3 ;85%) : via the carbonic anhydrase activity 3) Potassium (65%) : paracellular pathway 4) Glucose, amino acid (100%) and water (60%) : reabsorbed passively, maintaining osmolality in nearly constant level Ø Water permeability of the PCT is very high to maintain the osmolality of proximal fluid at nearly constant level, and the gradient from the tubule lumen to the surrounding interstitium is very small. DIURETICS THAT ACTS ON INHIBITORS Ø NaHCO3 reabsorption is initiated by : NaHCO3 – Na/H exchanger (NHE3) Ø Carbonic anhydrase inhibitors : block NaHCO reabsorption Ø Adenosine receptor antagonist : blocks NaCl reabsorption LOOP OF HENLE Ø Pumps Na, K and Cl out of the lumen into the interstitium Ø Provides the concentration gradient for the countercurrent concentrating mechanism Ø Diluting segment : thick ascending limb of the loop of Henle Ø Ca and Mg reabsorption Ø Na/K/2Cl cotransporter (NKCC2) Overview I. Introduction II. Renal Transport System III. Renal Autacoids IV. Basic Pharmacology of Diuretic Agents V. Agents that Alter Water Excretion (Aquaretics) VI. Clinical Pharmacology of Diuretic Agents Sodium bicarbonate reabsorption by the PCT is initiated by the action of a Na+/ H+^ exchanger (NHE3) located in the luminal membrane of the proximal tubule epithelial cell. This transport system allows Na+^ to enter the cell from the tubular lumen in exchange for a proton (H+) from inside the cell. As in all portions of the nephron, Na+/K+-ATPase in the basolateral membrane pumps the reabsorbed Na+^ into the interstitium in order to maintain a low intracellular Na+ concentration. The H+^ secreted into the lumen combines with bicarbonate (HCO 3 - ) to form H 2 CO 3 (carbonic acid), which is rapidly dehydrated to CO 2 and H 2 O by carbonic anhydrase. Carbon dioxide produced by dehydration of H 2 CO 3 enters the proximal tubule cell by simple diffusion, where it is then rehydrated back to H 2 CO 3 , facilitated by intracellular carbonic anhydrase. After dissociation of H 2 CO 3 , the H+^ is available for transport by the Na+/H+ exchanger, and the HCO 3 -^ is transported out of the cell by a basolateral membrane transporter

DIURETICS

Dr. Ma. Luisa Crisostomo | March 12, 2021 | Topic 2

Ø Thin ascending limb : relatively water impermeable but permeable to some solutes Ø Thick ascending limb : impermable to water; salt reabsoprtion in TAL, dilutes the tubular lumen (medullary TAL) contributes to hypertonicity à role: concentration of urine by the CD Ø NaCL transport system

  • NaCl transport system in the TAL is the Na/K/Cl cotransporter (Selectively block by loop diuretics) (Two cation and 2 anions are co- transported contributing to excess K accumulates inside the cells)
  • Back diffusion of K into the tubular lumen causes a lumen positive electrical potential that provides the driving force of cation like Ca and Mg via the paracellular pathway Ø INHIBITON OF SALT TRANSPORT IN THE TAL BY LOOP DIURETICS REDUCES THE LUMEN POSITIVE POTENTIAL CAUSES AN INCREASE IN URINARY EXCRETION OF DIVALENT CATIONS IN ADDITION TO DISTAL CONVOLUTED TUBULE Ø Actively pumps Na and Cl out of the lumen nephron- further dilutes the tubular fluids Ø 10 % Na reabsorbed Ø Impermeable to water Ø Ca is reabsorption via Na/Ca exchanger regulated by PTH COLLECTING TUBULE Ø Final site of NaCl reabsorption (2- 5 %)
  • Final Na concentration of the urine
  • Tight regulator of body fluid volume Ø Influenced by mineralocorticoids Ø Important site of K secretion and Na reabsorption : regulated by aldosterone Ø Na reabsorption
  • Epithelial Na Channel(ENaC)
  • Principal cells

INTERCALATED CELLS (ALPHA AND BETA)

Ø Primary sites of H (α cells) or HCO3 (β cells) secretion Ø ADH controls the permeability of the cells to water :

  • Regulates the insertion of pre-formed water channels (aquaporin-2 AQP2) à increasing water reabsorption and secretion of collecting tubules K accumulates IC, K leak out of K channel back into the lumen, contribute to more positivity in the lumen, forcing paracellular reabsorption of Mg and Ca Na that enters the principal cells from tubular is then transported back to blood via the basolateral NKAt, the lumen negative electric potential drives the transport of Cl back to the blood via the paracellular pathway and draws K out of cells thru apical membrane K channel. Reabsorption of Na via the ENaC and its coupled secretion of K are regulated by aldosterone by incrteasing the activity of both apical membrane channel and basolat memb NKAtpase à increased in transepithelial electric potential à increased in both Na reabsorption and K secretion.

DIURETICS

Dr. Ma. Luisa Crisostomo | March 12, 2021 | Topic 2

Table 1. Classification of diuretics and site of action Classification Site of action Carbonic anhydrase inhibitors Proximal tubule Osmotic diuretics Proximal tubule, loop of Henle, Collecting tubule Loop diuretics Ascending limb of the loop of Henle Thiazide diuretics Distal convolute tubule Potassium sparing diuretics Collecting tubule CARBONIC ANHYDRASE INHIBITORS Ø Carbonic anhydrase

  • Predominantly at the epithelial cells of the PCT
  • Catalyzes the dehydration of H 2 CO 3 to CO 2 at the luminal membrane
  • Catalyzes the rehydration of CO 2 to H 2 CO 3 ACETAZOLAMIDE (DIAMOX) Ø A sulfonamide derivative Ø Mechanism of action
  • Inhibits carbonic anhydrase which slows the following reaction : H + HCO 3 à H 2 O + CO
  • Inhibit the dehydration of H 2 CO 3
  • 85% HCO 3 reabsorption is inhibited at maximal dose
  • Drug effect occurs throughout the body
  • Block NaHCO 3 reabsorption
  • HCO 3 diuresis Ø Major clinical application
  • Carbonic anhydrase dependent HCO 3 and fluid transport sites other than kidney
  • Ciliary body of the eye secretes HCO 3 from the blood into the aqueous humor
  • Formation of CSF by the choroid plexus Ø Pharmacokinetics
  • Well absorbed after oral administration
  • Onset of action : 30 minutes
  • Duration : 12 hours
  • Excretion : proximal tubule Ø Pharmacodynamics
  • Depresses the HCO 3 reabsorption in the PCT
  • Significant HCO 3 losses : hyperchloremic metabolic acidosis Ø Clinical uses
  • Major clinical application : treatment of glaucoma
  • Dorzolamide, brinzolamide, dichlopheramide, methazolamide
  • Urinary alkalinization : prevent stone formation
  • Adjuvant in epilepsy and hypokalemic periodic paralysis
  • Slow the rate of CSF leakage in head trauma and tumor
  • Acute mountain sickness by reducing rate of CSF formation
  • Correction of metabolic alkalosis
  • Increase urinary phosphate excretion in hyperphosphatemia Ø Toxicity
  • Hyperchloremic metabolic acidosis
  • Renal stones : phosphaturia and hypercalciuria insoluble at alkaline pH
  • Renal potassium wasting
  • Drowsiness and paresthesia : large doses
  • Hypersensitivity reactions Ø Contraindications
  • Hyperammonemia : decrease urinary excretion of NH 4 due to alkalinization of the urine
  • Hepatic encephalopathy in cirrhosis ADENOSINE A1 RECEPTOR ANTAGONISTS Ø Interfere with the activation of NHE3 in the PCT and adenosine mediated enhancement of collecting tubule K secretion. Ø Caffeine and theophylline : weak diuretic effect Ø Aventri : under study SODIUM GLUCOSE CO-TRANSPORTER (SGLT2) INHIBITORS Ø PCT reabsorbed 90% of glucose vis SGLT Ø SGLT2 inhibitors : esult in glucose excretion of 30- 50 % Ø Dapagliflozin, canagliflozin, empagliflozin and ipragliflozin Ø Current indications : third line therapy for diabetes mellitus Ø Low incidence of hypoglycemia Ø Increase incidence of genital fungal infection and UTI LOOP DIURETICS Ø Classification and prototypes
  • Furosemide : prototype and sulfonamide derivative
  • Bumetanide : sulfonamide
  • Ethacrynic acid : phenoxyacetic acid Ø Rapidly absorbed
  • Most efficacious diuretic agent currently available
  • Diuretic response is extremely rapid following IV injection
  • Duration of effect : 2-3 hours
  • Half-life : dependent on renal function
  • Torsemide Hyperchloremic : depletion of HCO 3 leads to enhanced absorption of NaCl Urine alkalinization : makes uric acid and cysteine, soluble preventing stone form à acid urine makes them insoluble. Excessive alkalinization lead to calcium stone formation Phosphate and calcium are insoluble at alkaline Ph. K wasting occurs as more Na is presented to the collecting duct, enhance K secretion occur to maintain electrochemical gradient.

DIURETICS

Dr. Ma. Luisa Crisostomo | March 12, 2021 | Topic 2

ü Absorption : 1 hour ü Duration : 4 - 6 hours

  • Furosemide ü Absorption : 2 - 3 hours ü Duration : 2 - 3 hours Ø Pharmacodynamics
  • Inhibit NKCC2 in the TAL
  • Reduce the reabsorption of NaCl and the lumen positive potential that comes from K recycling
  • Cause an increase Ca and Mg excretion
  • Induce expression COX- 2
  • PGE2 inhibits salt transport in the TAL and increases renal action of loop diuretics
  • Activity is interfered by NSAIDs
  • Increases renal blood flow via PG actions on renal vasculature Ø Clinical uses
  • Treatment of edematous states (CHF and ascites)
  • Acute pulmonary edema in which a separate pulmonary vasodilating action may play a useful additive role
  • Sometimes used in hypertension if response to thiazide is inadequate but their short duration of action is a disadvantage
  • Treatment of severe hypercalcemia induced by a carcinoma : less common
  • Acute renal failure: increase urine flow and K excretion
  • Hyperkalemia
  • Anion overdose : bromide, chloride and iodide Ø Toxicity
  • Hypokalemic metabolic alkalosis
  • Hyperuricemia
  • Hypovolemia and cardiovascular complications
  • Ototoxicity : important toxic effect of the loop agents
  • Hypomagnesemia
  • Allergic reactions : sulfonamide THIAZIDE DIURETICS Ø Classification and prototype
  • Hydrochlorothiazide ü Prototype, sulfonamide derivative ü Thiazide for parenteral use
  • Chlorthalidone ü Slowly absorbed ü Longer action of duration
  • Indapamide ü New thiazide like agent with a significant vasodilating effect than Na diuretic effect
  • Chlorothiazide ü The parent compound, parenteral only, given large dose, not lipid soluble Ø Pharmacodynamics
  • Inhibit NaCl reabsorption from the luminal side of epithelial cells in the DCT
  • Blocks Na/Cl transporter NCC
  • Enhance Ca reabsorption
  • Useful in the prevention of calcium containing kidney stones caused by hypercalciuria
  • Can be inhibited by NSAIDs Ø Mechanism of action
  • Inhibit NaCl transporter (NCC) in the early segment of the DCT à inhibit and Na and Cl reabsorption à reduce the diluting capacity of the nephron
  • DCT : thiazide enhances Ø Effects (urinary excretion)
  • Full doses : produce a moderate Na and Cl diuresis à hypokalemic metabolic alkalosis
  • Reduced the blood pressure by reduction of the blood volume but with continued use these agents appear to reduce vascular resistance Ø Clinical use
  • Hypertension : major application, for which their long duration of action and moderate intensity of action are useful
  • Chronic therapy for edematous conditions (CHF) another common application
  • Nephrolithiasis caused by idiopathic hypercalciuria
  • Nephrogenic diabetes insipidus Ø Toxicity
  • Hypokalemic metabolic alkalosis and hyperuricemia: thiazide blunt uric acid secretion
  • Chronic therapy is often associated with potassium wasting
  • Hyperlipidemia, hyponatremia due to hypovolemia induced elevation of ADH
  • Allergic reactions, hyperglycemia: impaired glucose tolerance Ø Contraindications
  • Hepatic cirrhosis
  • Borderline renal failure POTASSIUM SPARING DIURETICS Ø Prevents potassium secretion by antagonizing the effects of aldosterone in collecting tubules Ø Classification and prototypes
  • Spironolactone, eplerenone : antagonist of aldosterone in the collecting tubules à has a slow onset and offset of action (24-72 hours)
  • Triamterene and amiloride : inhibitors of Na flux in the collecting tubule
  • Amiloride, triamterene, adenosine antagonist: inhibition of Na influx COX- 2 participates in the synthesis of PG from arachidonic acid. It inhibits salt transport in the TAL thus participates in renal action of loop diuretics Hypokalemic MA : inhibit salt reabsorption in TAL, loop increase Na delivery in collecting duct, increase secretion of K and H by the duct Ototoxicity : because NKCC is also present in the ear Uric acid : hypovolemia also enhances uric acid reabsorption

DIURETICS

Dr. Ma. Luisa Crisostomo | March 12, 2021 | Topic 2

Ø Clinical indications

  • Syndrome of Inappropriate ADH Secretion (SIADH) ü When water restriction is not effective
  • Other elevations of ADH Ø Toxicity
  • Extracellular volume expansion
  • Dehydration
  • Hyperkalemia
  • Hypernatremia and Nephrogenic DI
  • Hypertension : Tolvaptan CLINICAL PHARMACOLOGY OF DIURETIC AGENTS EDEMATOUS STATES Ø Heart failure
  • Renal retention of salt and water
  • Excessive use à decreased venous return and cardiac output Ø Kidney disease and renal failure
  • Little benefit in GFR < 5 mL/min
  • Oliguric and non-oliguric renal failure
  • Limitations with acetazolamide, K sparers and thiazides
  • High dose loop diuretics + metolazone Ø Hepatic cirrhosis
  • Portal hypertension, decreased oncotic pressures
  • Na retention during decreased renal perfusion, plasma volume, oncotic pressure
  • Increase plasma aldosterone
  • Loop diuretics + spirinolactone Ø Idiopathic edema NON- EDEMATOUS STATES Ø Hypertension
  • Thiazides Ø Nephrolithiasis
  • Calcium PO 4 and oxalate
  • Thiazide enhance Ca reabsorption Ø Hypercalcemia
  • Loop diuretics promote Ca diuresis
  • Loop diuretics + saline infusion Ø Diabetes insipidus
  • ADH effective only in central DI
  • Thiazide effective in Nephrogenic DI R E F E R E N C E S
  1. Diuretics. Dr. Crisostomo, 2021. (Annotated Lecture)
  2. Basic and Clinical Pharmacology. (14th^ ed). Katzung.